Holen Sie sich die Stockscreener-App
0.631
3.52%
-0.023
Handel nachbörslich:
.64
0.009
+1.43%
Finanzdaten der Pds Biotechnology Corporation-Aktie (PDSB)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-07-01 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
8.1401
|
- | 9.1058 | 7.3606 | 10.18 |
| Operating Income/Loss |
-8.1401
|
- | -9.1058 | -7.3606 | -10.18 |
| Income/Loss From Continuing Operations Before Tax |
4.50%
-9.0094
|
-9.4342 | -9.6588 | -7.9524 | -10.73 |
| Income Tax Expense/Benefit |
-
|
- | -1.1698 | - | - |
| Income/Loss From Continuing Operations After Tax |
4.50%
-9.0094
|
-9.4342 | -8.489 | -7.9524 | -10.73 |
|
Net Income/Loss
|
4.50%
-9.0094
|
-9.4342 | -8.489 | -7.9524 | -10.73 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
46.87
|
- | 40.52 | 0.3448 | 36.81 |
| Diluted Average Shares |
46.87
|
- | 40.52 | 0.3448 | 36.81 |
| Basic Earnings Per Share |
-0.19
|
- | -0.21 | -0.21 | -0.29 |
| Diluted Earnings Per Share |
-0.19
|
- | -0.21 | -0.21 | -0.29 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):